Skip to content
PICO Portalanswers from OpenAlex

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer

PaperCitations, authors & open-access status

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer have?

PICO Portalcitation count

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer has 144 citations in the OpenAlex counts PICO Portal stores.

When was The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer published?

PICO Portalyear

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer has 2018 year in the PICO Portal index.

What is the open-access status of The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer?

PICO Portaloa status

The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer has hybrid oa status in the PICO Portal index.

What is the DOI of The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer?

PICO Portaldoi

The DOI for The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer is on the source record.

What is the PMID of The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer?

PICO Portalpmid

The PMID for The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer is on the source record.

What is the OpenAlex record for The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer?

PICO Portalopenalex

The OpenAlex for The mitochondrial citrate carrier, SLC25A1, drives stemness and therapy resistance in non-small cell lung cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial